Market revenue in 2023 | USD 42.9 million |
Market revenue in 2030 | USD 90.4 million |
Growth rate | 11.2% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 56.88% in 2023. Horizon Databook has segmented the Japan deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Long-term cost-effectiveness associated with deep brain stimulation devices is a high-impact rendering driver of Japan market. According to a study published in NCBI, deep brain stimulation is a cost-effective procedure and delivers sustained benefits.
Hence, it is preferred over other conventional treatment options. Major companies operating in Japan deep brain stimulation devices market include Shenzhen Yingchi Technology Co. Ltd., Medtronic plc, Abbott, and Boston Scientific Corp., among others.
Moreover, technological innovations, such as incorporation of robotic assistance, to minimize human errors during surgeries and extensive R&D capabilities are responsible for the country’s largest market share in Asia Pacific.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account